JP2003528925A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528925A5
JP2003528925A5 JP2001572128A JP2001572128A JP2003528925A5 JP 2003528925 A5 JP2003528925 A5 JP 2003528925A5 JP 2001572128 A JP2001572128 A JP 2001572128A JP 2001572128 A JP2001572128 A JP 2001572128A JP 2003528925 A5 JP2003528925 A5 JP 2003528925A5
Authority
JP
Japan
Prior art keywords
use according
virus
therapeutic composition
equine
respiratory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001572128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003528925A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/008968 external-priority patent/WO2001074386A2/en
Publication of JP2003528925A publication Critical patent/JP2003528925A/ja
Publication of JP2003528925A5 publication Critical patent/JP2003528925A5/ja
Pending legal-status Critical Current

Links

JP2001572128A 2000-04-03 2001-03-21 低温適応型ウマインフルエンザウイルス Pending JP2003528925A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19432500P 2000-04-03 2000-04-03
US60/194,325 2000-04-03
PCT/US2001/008968 WO2001074386A2 (en) 2000-04-03 2001-03-21 Cold-adapted equine influenza viruses

Publications (2)

Publication Number Publication Date
JP2003528925A JP2003528925A (ja) 2003-09-30
JP2003528925A5 true JP2003528925A5 (https=) 2008-04-24

Family

ID=22717146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001572128A Pending JP2003528925A (ja) 2000-04-03 2001-03-21 低温適応型ウマインフルエンザウイルス

Country Status (8)

Country Link
US (2) US7029903B2 (https=)
EP (1) EP1267920B1 (https=)
JP (1) JP2003528925A (https=)
AT (1) ATE350056T1 (https=)
AU (2) AU2001249300B2 (https=)
CA (1) CA2403979A1 (https=)
DE (1) DE60125736D1 (https=)
WO (1) WO2001074386A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004003572A1 (de) 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
ES2496315T3 (es) * 2005-10-19 2014-09-18 University Of Florida Research Foundation, Incorporated Materiales para el control de la enfermedad respiratoria en caninos
EP2391713A1 (en) 2009-01-30 2011-12-07 The Board Of Regents For Oklahoma State University Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
CA2756206C (en) 2009-03-27 2025-05-13 Academia Sinica METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST A VIRUS
RU2586294C2 (ru) * 2010-03-10 2016-06-10 Интервет Интернэшнл Б.В. Способ защиты от заболеваний, вызываемых вторичными патогенами
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
EP2854847B1 (en) * 2012-05-31 2019-08-07 Zoetis Services LLC Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections
JP6560056B2 (ja) * 2015-08-07 2019-08-14 ウィスコンシン アルムニ リサーチ ファンデイション H3型ウマa型インフルエンザウイルス
JP2018088928A (ja) * 2018-02-13 2018-06-14 ウィスコンシン アルムニ リサーチ ファンデイション H3型ウマa型インフルエンザウイルス

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518347A (en) 1965-05-28 1970-06-30 Inst Microbiologie Et D Hygien Vaccine for equine influenza
US3992522A (en) 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
DE3381376D1 (de) 1982-04-16 1990-05-03 Cornell Res Foundation Inc Temperaturempfindliche reassortierende viren und impfstoff gegen pferdeinfluenza.
US4683137A (en) 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4631191A (en) 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
US4920213A (en) 1985-06-20 1990-04-24 Biotechnology Research Partners, Ltd. Method and compositions useful in preventing equine influenza
US5149531A (en) 1990-06-27 1992-09-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Similar Documents

Publication Publication Date Title
Rupprecht et al. Human infection due to recombinant vaccinia–rabies glycoprotein virus
Růžek et al. Omsk haemorrhagic fever
JP2003528925A5 (https=)
JP2021116296A (ja) コロナウイルス感染の治療におけるファビピラビルの使用
CA2339089A1 (en) Cold-adapted equine influenza viruses
Bonville et al. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents
WO2001060849A3 (en) Cold-adapted equine influenza viruses
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
LT5079B (lt) Avies pararaupų viruso kamienų panaudojimas antivirusinių ir priešvėžinių vaistų gamybai
CN105582526A (zh) 三叶因子2在制备治疗及预防肺/支气管急性炎症疾病药物方面的应用
WO2001074386A3 (en) Cold-adapted equine influenza viruses
TW565452B (en) A pharmaceutical composition for use in inhibiting swine infertility and respiratory syndrome virus (SIRSV) proliferation in swine in need of treatment
BRPI0418093A (pt) vìrion de um pneumovìrus, método para produzir vìrions pneumovirais, composição, uso de um vìrion, e, método para a prevenção ou tratamento de uma infecção pneumoviral
Lapin et al. Monkey viral pathology in the Sukhum colony and modeling human viral infections
DE69731106D1 (de) Neue pikcornaviren, impfstoffe und diagnostische kits
JP4846598B2 (ja) 弱毒化ウサギ粘液腫ウイルスに基づくモノ非特異的免疫誘導剤
US20230030607A1 (en) Novel oxygen pulse therapy method for treating COVID19 and viral, bacterial, fungal or parasitic respiratory and other diseases
El Fakhry et al. Dissemination of Encephalitozoon intestinalis, a causative agent of human microsporidiosis, in IFN‐γ receptor knockout mice
Talukdar et al. Cancer: infection and vaccines
TW202200196A (zh) 用人α-1抗胰蛋白酶治療病毒感染的方法
BROWNE Near fatal envenomation from the funnel-web spider in an infant
WO2021045073A1 (ja) 鼻腔にウイルス特異的抗体を誘導可能な季節性インフルエンザワクチン
MORIMOTO et al. Lactic dehydrogenase virus infection enhances parasite egg production and inhibits eosinophil and mast cell responses in mice infected with the nematode Nippostrongylus brasiliensis
CN118252916A (zh) 一种抑制不同类型猪繁殖与呼吸综合症病毒感染的14-3-3γ蛋白及其应用
JP2007534664A5 (https=)